New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 27, 2014
07:31 EDTBIIBBiogen price target raised to $355 from $291 at Canaccord
Canaccord believes Biogen's SMNRx/SMA opportunity is $2B+ in potential peak sales with potential 2017 approval. The firm believes the data is compelling and that Biogen will opt into the ISIS SMA program and has a high probability of success. Shares are Buy rated.
News For BIIB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 21, 2015
10:58 EDTBIIBDeutsche Bank biotech analyst holds an analyst/industry conference call
Subscribe for More Information
May 15, 2015
09:31 EDTBIIBAmerican Thoracic Society to hold a conference
ATS 2015 Conference is being held in Denver on May 15-20.
May 13, 2015
07:32 EDTBIIBBiogen names Matt Griffiths as CIO
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use